These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 9357798
1. Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance. Ahrén B, Pacini G. Am J Physiol; 1997 Oct; 273(4):E701-7. PubMed ID: 9357798 [Abstract] [Full Text] [Related]
2. Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance. Larsson H, Ahrén B. Diabetologia; 1996 Sep; 39(9):1099-107. PubMed ID: 8877295 [Abstract] [Full Text] [Related]
3. Androgen activity as a risk factor for impaired glucose tolerance in postmenopausal women. Larsson H, Ahrén B. Diabetes Care; 1996 Dec; 19(12):1399-403. PubMed ID: 8941471 [Abstract] [Full Text] [Related]
4. Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. Larsson H, Ahrén B. Diabetes Care; 2000 May; 23(5):650-7. PubMed ID: 10834425 [Abstract] [Full Text] [Related]
5. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness. Osei K, Gaillard T, Schuster DP. Diabetes Care; 1997 Mar; 20(3):396-404. PubMed ID: 9051394 [Abstract] [Full Text] [Related]
6. Decreased insulin-mediated but not non-insulin-dependent glucose disposal rates in glucose intolerance and type II diabetes in African (Ghanaian) immigrants. Osei K, Schuster DP. Am J Med Sci; 1996 Mar; 311(3):113-21. PubMed ID: 8615385 [Abstract] [Full Text] [Related]
7. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance. Rask E, Olsson T, Söderberg S, Holst Jj Jj, Tura A, Pacini G, Ahrén B. Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768 [Abstract] [Full Text] [Related]
8. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose. Kanat M, Norton L, Winnier D, Jenkinson C, DeFronzo RA, Abdul-Ghani MA. Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243 [Abstract] [Full Text] [Related]
9. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Rizza R. Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502 [Abstract] [Full Text] [Related]
10. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes? Bacha F, Gungor N, Lee S, Arslanian SA. Diabetes Care; 2009 Jan; 32(1):100-5. PubMed ID: 18835946 [Abstract] [Full Text] [Related]
11. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y. Diabetes Care; 1997 Oct; 20(10):1562-8. PubMed ID: 9314636 [Abstract] [Full Text] [Related]
12. Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance. Ehrmann DA, Breda E, Cavaghan MK, Bajramovic S, Imperial J, Toffolo G, Cobelli C, Polonsky KS. Diabetologia; 2002 Apr; 45(4):509-17. PubMed ID: 12032626 [Abstract] [Full Text] [Related]
13. Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion. Fritsche A, Stefan N, Hardt E, Häring H, Stumvoll M. Diabetologia; 2000 Jul; 43(7):852-8. PubMed ID: 10952457 [Abstract] [Full Text] [Related]
14. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects. Miyazaki Y, Akasaka H, Ohnishi H, Saitoh S, DeFronzo RA, Shimamoto K. Hypertens Res; 2008 Jul; 31(7):1357-63. PubMed ID: 18957806 [Abstract] [Full Text] [Related]
15. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Faerch K, Vaag A, Holst JJ, Glümer C, Pedersen O, Borch-Johnsen K. Diabetologia; 2008 May; 51(5):853-61. PubMed ID: 18317726 [Abstract] [Full Text] [Related]
16. The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance. Abdul-Ghani MA, Matsuda M, Jani R, Jenkinson CP, Coletta DK, Kaku K, DeFronzo RA. Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E401-6. PubMed ID: 18492770 [Abstract] [Full Text] [Related]
17. Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes. Lemieux S, Bédard A, Piché MÈ, Weisnagel SJ, Corneau L, Bergeron J. Clin Endocrinol (Oxf); 2011 Mar; 74(3):340-5. PubMed ID: 21092050 [Abstract] [Full Text] [Related]
18. Insulin sensitivity and first-phase insulin secretion in obese Chinese with hyperglycemia in 30 and/or 60 min during glucose tolerance tests. Hong J, Zhang YF, Gu WQ, Zhang YW, Su YX, Chi ZN, Wang WQ, Li XY, Ning G. Endocrine; 2008 Mar; 34(1-3):75-80. PubMed ID: 18979203 [Abstract] [Full Text] [Related]
20. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Faerch K, Vaag A, Holst JJ, Hansen T, Jørgensen T, Borch-Johnsen K. Diabetes Care; 2009 Mar; 32(3):439-44. PubMed ID: 19056613 [Abstract] [Full Text] [Related] Page: [Next] [New Search]